Thomas Hayes bought Albemarle stock and sold Palantir stock in June 2025.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Thomas Hayes bought Albemarle stock and sold Palantir stock in June 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Thomas Hayes
professor of political science
Nothing else this week.
-
Albemarle Corporation
American specialty chemicals manufacturing company
Nothing else this week.
-
Palantir Technologies
American software and services company, specializing in data analysis
- Controversy surrounds the Palantir-run federated data platform for the NHS, with concerns raised by figures like James Frith and a £50m contract block due to company controversy.
- Morgan Stanley upped its price objective and gave a buy rating, while Jefferies reiterated an underperform rating for Palantir Technologies.
Coverage
Newest first; wire copies grouped- Unknown outlet